Current concepts of antibacterial therapy of nosocomial urinary tract infections

##plugins.themes.bootstrap3.article.sidebar##

PDF (Русский)
Published: Dec 16, 2016
DOI: https://doi.org/10.30841/2307-5090.4(59).2016.104372
Keywords:
nosocomial urinary tract infection, Pseudomonas aeruginosa, antibacterial therapy,

##plugins.themes.bootstrap3.article.main##

О. Д. Нікітін
Национальный медицинский университет имени А.А. Богомольца, г. Киев, Ukraine

Abstract

The article presents data from a study of clinical and bacteriological efficacy and safety of the Brakson (tobramycin) in the treatment of nosocomial urinary tract infections. In accordance with the results demonstrated whether the use of antibacterial drugs in patients who are infected with the urinary tract Pseudomonas aeruginosa. According to the indicators of the antimicrobial activity of laboratory studies of the drug Brakson its efficiency is 78.9%. The clinical effect of therapy with a high level of safety noted 94.7% of patients. This allows us to recommend Brakson in nosocomial urinary tract infec tions as a monotherapy.

##plugins.themes.bootstrap3.article.details##

How to Cite
Нікітін, О. Д. (2016). Current concepts of antibacterial therapy of nosocomial urinary tract infections. Health of Man, (4(59), 77–82. https://doi.org/10.30841/2307-5090.4(59).2016.104372
Issue
No. 4(59) (2016)
Section
Urology
Copyright (c) 2020 О. Д. Нікітін

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors retain the copyright and grant the journal the first publication of original scientific articles under the Creative Commons Attribution 4.0 International License, which allows others to distribute work with acknowledgment of authorship and first publication in this journal.

Author Biography

О. Д. Нікітін, Национальный медицинский университет имени А.А. Богомольца, г. Киев

O. Nikitin

References

Пасєчніков С.П., Нашеда С.В., Царьова О.М. Бактеріальна ефективність аміноглікозидів в умовах зростаючої антибіотикорезистент ності уропатогенів// Медицинские аспекты здоровья мужчины. – 2016. – No 2 (21). – С. 36–39.

Рафальский В.В., Ходневич Л.В. Влияние резистентности возбудителей инфекций мочевыводящих путей на исходы антибактериальной терапии / Урология. – 2008 (4). – Р. 3–9.

Dodd MC, Stillman WВ. The in vitro bacteriostatic action of some simple furan derivatives. J Pharmacol Exp Ther 1944; 82: 11–18.

Foxman B. Epidemiology of urinary tract infections: incidence, morbidity and economic costs // Am. J. Med. – 2002. – Vol. 113 (Suppl. 1A). – P. 5S–13S.

Gerding D.N., Larson T.A., Hughes R.A. et al. Aminoglycoside resistance and aminoglycoside usage: ten years of experience in one hospital / Antimicrob Agents Chemother. – 1991; 35: 1284–1290.

Grabe M., Bjerklund–Johansen T., Botto H., Naber K. and Bishop M. /Guidelines on urological infections. – 2010: European Association of Urology.

Grude N, Tveten Y, Jenkins A, Kristiansen BE. Uncomplicated urinary tract infections. Bacterial findings and efficacy of empirical antibacterial treat ment. Scand J Prim Health Care 2005; 23(2):115–119.

Mesa Espaсola de Normalizaciуn de la Sensibilidad y Resistencia a los Antimicrobianos. Recomendaciones del grupo MENSURA para la selecciуn de antimicrobianos en el estudio de la sensibilidad y criterios para la interpretaciуn del antibiograma. MENSURA, Madrid, Spain. 2005.

Nicolle LE Urinary tract infection: traditional pharmacologic therapies. Am J Med 2002;113 [Suppl 1A]: 35S 44S]

Ramakrishnan K, Scheid DC. Diagnosis and management of acute pyelonephritis in adults. Am J Fam Phys 2005; 71(5): 933–941.

Tolkoff Rubin NE, Cotran RS, Rubin RH. Urinary tract infections, pyelonephritis, and reflux nephropathy. In: Brenner BM, ed. The Kidney, sixthed. W.B. Saunders, Philadelphia et al., 2000; 1449–1508.

Wagenlehner FM, Naber KG. Treatment of bacterial urinary tract infections: presence and future. Eur Urol 2006; 49(2): 235–244.

Williams DH, Schaeffer AJ. Current concepts in urinary tract infections. Minerva Urol Nephrol 2004; 56(1): 15–31.